Attention Deficit Hyperactivity Disorder Clinical Trial
Official title:
A Pilot Randomized Control Trial of the Task-Based Grounding Program
Verified date | November 2021 |
Source | Dartmouth-Hitchcock Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to improve the availability of brief interventions to help children with defiant, aggressive and disruptive behaviors by creating a brief scalable intervention for parents delivered via telehealth. As phase 1 study, we are conducting a 2-arm pilot feasibility RCT in order the intervention, measures, and procedures to be used in a larger efficacy trial. The first arm will include a 3-session behavioral therapy treatment we call Task-Based Grounding and the second arm will be an enhanced treatment as usual comparison group.
Status | Completed |
Enrollment | 28 |
Est. completion date | October 1, 2021 |
Est. primary completion date | October 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Years and older |
Eligibility | Inclusion Criteria: - Participating parent-child dyads must include a child between the ages of 9-14 years old and adult over the age of 18. - The child must have a Vanderbilt Oppositional Defiant Disorder score >3 - The participating caregiver must be a legal guardian of participating child Exclusion Criteria (child refers to the primary participant's child) - Child ever been hospitalized for a psychiatric problem - Child ever attempted suicide or stated that they had a plan to attempt suicide within the past year. - Child ever engaged in self-harm behaviors - Child has significant legal history such as adjudicated of a crime or been in diversion - Child has ever been diagnosed with: Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, Intellectual Disability or Developmental Delay, Speech or Hearing Delay, Autism Spectrum Disorder, Schizophrenia or another psychotic disorder, A substance abuse disorder (or had serious concerns about substance use). - Parent can communicate in spoken English - Parent is under the age of 18. |
Country | Name | City | State |
---|---|---|---|
United States | Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire |
Lead Sponsor | Collaborator |
---|---|
Dartmouth-Hitchcock Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of referred participants | Feasibility of recruitment will be measured by number of participants referred | Through study completion, approximately 5 months. | |
Primary | Number of participants who screen positive | Feasibility of recruitment will be measured by number of participants who screen positive | Through study completion, approximately 5 months. | |
Primary | Change from Baseline Session attendance at visit 3 | Feasibility of the participant retention in the program will be measured by session attendance by participants | Session attendance will be taken at Session 1 (week 0) and Session 3 (week 6) | |
Primary | Number of participants enrolled | Feasibility of recruitment will be measured by number of participants enrolled | Through study completion, approximately 5 months. | |
Primary | Number of participants who complete all assessment measures | Feasibility of assessment measures will be measured by number of participants who complete assessment measures | Through study completion, approximately 5 months. | |
Primary | Fidelity of the training provided | as measured by having a trained listener code and score fidelity using a checklist developed specifically for the content of each session. Audio recording of intervention sessions will be used. There are 35 items on the checklist, each worth 1pt. Score will be in terms of percentage, with a minimum score of 0 and a maximum score 100%. | Through study completion, approximately 5 months. | |
Primary | Intervention acceptability as measured by the Treatment Evaluation Inventory Short Form | as measured by Treatment Evaluation Inventory Short Form post intervention which measures intervention acceptance. The established cut off scores for determining if a treatment is acceptable is a score of 27. Min score possible is 0, max score possible is 32. Higher scores indicate greater acceptability. | Follow-up/post intervention (up to 10 weeks) | |
Primary | Intervention Acceptability as measured by the Therapy Attitude Inventory | as measured by the Therapy Attitude Inventory post intervention which measures acceptability of behavioral parent trainings. Min score of 1 is possible, max score of 50 is possible. Higher scores indicate greater acceptability. | Follow-up/post intervention (up to 10 weeks) | |
Primary | Intervention Acceptability as measured by the Participant Experiences Questionnaire | as measured by the Participant Experiences Questionnaire which measures acceptability of each skill module included in the program and is specific to program content. Min score of 0 possible, max score of 36 possible. Higher scores indicate greater acceptability. | Follow-up/post intervention (up to 10 weeks) | |
Primary | Acceptability as measured by qualitative interview | as measured by 30 minute semi-structured qualitative interview with participants conducted by a research assistant trained and supervised by the study PI | Follow-up/post intervention (up to 10 weeks) | |
Secondary | Adherence to the intervention | as measured by daily logs that track both children's aggressive and defiant behaviors and parenting behaviors. A count of each time a parent used a skill from the program will be used to estimate adherence and assess whether they matched the appropriate skills to the reported misbehaviors. | Available for completion every day for 10 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06129396 -
Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT04779333 -
Lifestyle Enhancement for ADHD Program 2
|
N/A | |
Recruiting |
NCT05935722 -
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
|
N/A | |
Completed |
NCT03148782 -
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
|
N/A | |
Completed |
NCT04832737 -
Strength-based Treatment Approach for Adults With ADHD
|
N/A | |
Recruiting |
NCT04631042 -
Developing Brain, Impulsivity and Compulsivity
|
||
Recruiting |
NCT05048043 -
Development of a Game-supported Intervention
|
N/A | |
Completed |
NCT03337646 -
Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
|
Phase 4 | |
Not yet recruiting |
NCT06406309 -
Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD
|
N/A | |
Not yet recruiting |
NCT06454604 -
Virtual Reality Treatment for Emerging Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT06080373 -
Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT02477280 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance
|
Phase 4 | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02829970 -
Helping College Students With ADHD Lead Healthier Lifestyles
|
N/A | |
Completed |
NCT02473185 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest
|
Phase 4 | |
Completed |
NCT02390791 -
New Technologies to Help Manage ADHD
|
N/A | |
Completed |
NCT02780102 -
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
|
N/A | |
Completed |
NCT02555150 -
A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
|
Phase 3 | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Recruiting |
NCT04175028 -
Neuromodulation of Executive Function in the ADHD Brain
|
N/A |